Zhu et al. found that entinostat not only increased the expression of MICA/B on osteosarcoma cells but also simultaneously increased the expression of NKG2D on primary human NK cells to augment the activation pathways for NK cell recognition of cancer cells (259). The gene discussed is KLRK1; the disease is osteosarcoma.